Market Performance
Price Movement (24 hrs ending 06:45 PM CET, Friday 23rd) Anika Therapeutics (ANIK) increased by 2.38 %. Current trading price: USD 21.19.
Trading Volume and Market Capitalization
Shares outstanding: 13.4 million.
Market capitalization: USD 275.7 million.
Volume in last 24 hrs: USD 1.3 million of shares traded.
Historical Technical Levels
200‑day simple moving average: USD 15.72.
52‑week high: USD 22.88 (08 Oct 2026).
52‑week low: USD 9.01 (28 Jan 2026).
Month‑to‑Date Performance Since the end of last month, ANIK has gained 3.48 %.
Earnings Announcement
Anika Therapeutics will release its third‑quarter 2026 financial results prior to the market opening on Friday, 6 November.
- Conference Call: 08:30 AM Eastern Time.
- Access: Participants may join via telephone or via webcast and accompanying presentation materials on the company’s investor‑relations website.
- Focus: The announcement will emphasize the company’s hyaluronic‑acid products for osteoarthritis and orthopedic regeneration, reaffirming its commitment to patient‑centric outcomes and a differentiated product portfolio.
Peer Comparison (Last 24 hrs)
| Ticker | % Change | Current Price | Market Cap (USD M) | P/E (if disclosed) |
|---|---|---|---|---|
| ALDF (Aldel Ii) | 0 % | 10.81 | 328 | — |
| PTLO (Portillo’s) | –5.47 % | 4.22 | 328.1 | 22.93 |
| BEAG (Bold Eagle Acquisition Cor) | –0.66 % | 10.50 | 329.2 | 42.58 |
| AVIR (Atea) | –8.62 % | 4.01 | 327.2 | — |
| ENTA (Enanta) | 2.74 % | 11.39 | 329.4 | — |
Company Profile
Anika Therapeutics, Inc. is a global joint‑preservation company headquartered in Bedford, United States. The firm specializes in early‑intervention orthopedic care and the development of minimally invasive products. It operates within the Health Care sector, focusing primarily on biotechnology. Anika Therapeutics went public on the Nasdaq stock exchange on 29 April 1993.
